TRDA

13.06

2.92% 0.37

Pre-mercato: 13.39 0.33 +2.53%

Entrada Therapeutics Inc (TRDA)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Precedente Chiudi:

$12.69

Aprire:

$12.83

Volume 24 ore:

93,433

Relative Volume:

0.80

Capitalizzazione di mercato:

$488.70M

Reddito:

$239.40M

Utile/perdita netta:

$104.44M

Rapporto P/E:

4.4122

EPS:

2.96

Flusso di cassa netto:

$-18.50M

1 W Prestazione:

+4.56%

1M Prestazione:

-25.75%

6M Prestazione:

-23.09%

1 anno Prestazione:

-10.85%

Intervallo 1D:

$12.71

$13.15

Intervallo di 1 settimana:

$12.02

$13.15

Portata 52W:

$11.35

$21.79

Entrada Therapeutics Inc Stock (TRDA) Company Profile

Nome

Entrada Therapeutics Inc

Settore

Healthcare (1176)

Industria

Biotechnology (685)

Telefono

857-305-1825

Indirizzo

ONE DESIGN CENTER PLACE, BOSTON

Dipendente

177

Cinguettio

Prossima data di guadagno

2024-08-12

Ultimi documenti SEC

TRDA's Discussions on Twitter

Confronta TRDA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TRDA Entrada Therapeutics Inc	13.06	488.70M	239.40M	104.44M	-18.50M	2.96
VRTX Vertex Pharmaceuticals Inc	427.89	110.19B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	687.80	75.58B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	647.39	38.71B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	264.99	34.18B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.25	28.11B	3.30B	-501.07M	1.03B	-2.1146

Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-06	Iniziato	ROTH MKM	Buy
2024-01-05	Iniziato	Oppenheimer	Outperform
2023-04-03	Iniziato	H.C. Wainwright	Buy

Entrada Therapeutics Inc Borsa (TRDA) Ultime notizie

Jan 16, 2025

Barclays PLC Buys 30,585 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jan 16, 2025

Jan 15, 2025

Entrada Therapeutics : Corporate Presentation - Marketscreener.com

Jan 15, 2025

Jan 12, 2025

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Sold by Jane Street Group LLC - Defense World

Jan 12, 2025

Jan 11, 2025

The Market Doesn't Like What It Sees From Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Revenues Yet As Shares Tumble 26% - Simply Wall St

Jan 11, 2025

Jan 10, 2025

Entrada Therapeutics (NASDAQ:TRDA) Trading Down 7.6%Here's Why - MarketBeat

Jan 10, 2025

Jan 02, 2025

Geode Capital Management LLC Raises Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Jan 02, 2025

Geode Capital Management LLC Has $9.21 Million Stake in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jan 02, 2025

Jan 01, 2025

Barclays PLC Increases Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jan 01, 2025

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Bought by Barclays PLC - MarketBeat

Jan 01, 2025

Dec 30, 2024

Best Momentum Stocks to Buy for December 30th - Yahoo Finance

Dec 30, 2024

Dec 28, 2024

State Street Corp Has $7.50 Million Stock Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Dec 28, 2024

Where are the Opportunities in (TRDA) - Stock Traders Daily

Dec 28, 2024

Dec 22, 2024

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Dec 22, 2024

Dec 18, 2024

Entrada Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Marketscreener.com

Dec 18, 2024

Dec 17, 2024

(TRDA) Proactive Strategies - Stock Traders Daily

Dec 17, 2024

Dec 16, 2024

Recent Price Trend in Entrada Therapeutics (TRDA) is Your Friend, Here's Why - MSN

Dec 16, 2024

Dec 15, 2024

Charles Schwab Investment Management Inc. Has $2.97 Million Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Dec 15, 2024

Dec 13, 2024

XTX Topco Ltd Takes $634,000 Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Dec 13, 2024

Dec 10, 2024

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Sold by Fmr LLC - MarketBeat

Dec 10, 2024

Dec 09, 2024

Is Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Recent Stock Performance Tethered To Its Strong Fundamentals? - Simply Wall St

Dec 09, 2024

Dec 08, 2024

Entrada Therapeutics (NASDAQ:TRDA) Upgraded at Roth Capital - Defense World

Dec 08, 2024

Dec 07, 2024

Roth Mkm Begins Coverage on Entrada Therapeutics (NASDAQ:TRDA) - MarketBeat

Dec 07, 2024

Roth MKM starts ‘overlooked’ Entrada Therapeutics with Buy rating - Yahoo Finance

Dec 07, 2024

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Purchased by Janus Henderson Group PLC - MarketBeat

Dec 07, 2024

Jacobs Levy Equity Management Inc. Has $3.23 Million Stock Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Dec 07, 2024

Dec 03, 2024

Insider Sell Alert: Natarajan Sethuraman Sells Shares of Entrada Therapeutics Inc (TRDA) - GuruFocus.com

Dec 03, 2024

Entrada Therapeutics CFO sells shares worth nearly $120,000 By Investing.com - Investing.com Nigeria

Dec 03, 2024

Entrada Therapeutics president sells $320,619 in stock By Investing.com - Investing.com Nigeria

Dec 03, 2024

Entrada Therapeutics CFO sells shares worth nearly $120,000 - Investing.com India

Dec 03, 2024

Entrada Therapeutics president sells $320,619 in stock - Investing.com

Dec 03, 2024

Entrada Therapeutics stock hits 52-week high at $20.5 By Investing.com - Investing.com Canada

Dec 03, 2024

Nov 28, 2024

Massachusetts Financial Services Co. MA Invests $1.11 Million in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Nov 28, 2024

Nov 26, 2024

Entrada Therapeutics (TRDA) Is a Great Choice for 'Trend' Investors, Here's Why - MSN

Nov 26, 2024

(TRDA) Investment Analysis and Advice - Stock Traders Daily

Nov 26, 2024

Connor Clark & Lunn Investment Management Ltd. Has $2.22 Million Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Nov 26, 2024

Nov 17, 2024

Los Angeles Capital Management LLC Makes New $542,000 Investment in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Nov 17, 2024

Nov 15, 2024

Insider Sale at Entrada Therapeutics Inc (TRDA) by President of Research & Development - GuruFocus.com

Nov 15, 2024

Nov 13, 2024

500: Something went wrong - Investing.com UK

Nov 13, 2024

Entrada Therapeutics stock hits 52-week high at $20.28 By Investing.com - Investing.com Canada

Nov 13, 2024

Nov 11, 2024